These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25314012)

  • 21. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl transdermal absorption linked to pharmacokinetic characteristics in patients undergoing palliative care.
    Van Nimmen NF; Poels KL; Menten JJ; Godderis L; Veulemans HA
    J Clin Pharmacol; 2010 Jun; 50(6):667-78. PubMed ID: 20097932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disposition of fentanyl in human blood].
    Lehmann KA; Schmitz KF; Daub D
    Anaesthesist; 1983 Jul; 32(7):329-34. PubMed ID: 6614420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.
    Wang C; Williams NS
    J Pharm Biomed Anal; 2013 Mar; 75():112-7. PubMed ID: 23312388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
    Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
    Freise KJ; Savides MC; Riggs KL; Owens JG; Newbound GC; Clark TP
    J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():21-6. PubMed ID: 22731772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of variability in fentanyl plasma levels during steady-state transdermal delivery in older nursing home residents.
    Rigler SK; Wiggins S; Mahnken J; Reed GA
    J Am Geriatr Soc; 2012 Oct; 60(10):1986-8. PubMed ID: 23057458
    [No Abstract]   [Full Text] [Related]  

  • 33. Three-cycle fentanyl patch system contributes to stable control of plasma fentanyl concentration in gynecologic cancer pain patients.
    Kanamori C; Kanamori T; Tanaka Y; Kanzaki H
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):79-84. PubMed ID: 21482380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective plasma protein binding of amlodipine.
    Maddi S; Yamsani MR; Seeling A; Scriba GK
    Chirality; 2010 Feb; 22(2):262-6. PubMed ID: 19496159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of age on plasma protein binding of sufentanil.
    Meistelman C; Benhamou D; Barre J; Levron JC; Mahe V; Mazoit X; Ecoffey C
    Anesthesiology; 1990 Mar; 72(3):470-3. PubMed ID: 2137997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The stereoselective binding of praziquantel enantiomers to plasma proteins].
    He K; Quan YZ; Qiu ZY
    Yao Xue Xue Bao; 1991; 26(7):488-92. PubMed ID: 1805506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the use of a transdermal fentanyl patch in cats.
    Scherk-Nixon M
    J Am Anim Hosp Assoc; 1996; 32(1):19-24. PubMed ID: 8963731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
    Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
    Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transdermal fentanyl for the management of cancer pain: a survey of 1,664 elderly patients].
    Yu SY; Sun Y; Zhang HC; Wu YL; Qin SK; Xie GR; Liu SJ; Sui G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1931-5. PubMed ID: 14703423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.